| No headlines available for NCLEX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
132.61M |
| Category: |
Small Growth |
| Total Expense Ratio: |
0.93% |
|
| PERFORMANCE & RISK | 31-Jan-10
| YTD Return: |
-2.70% |
| 5y Avg Return: |
2.61% |
| Rank in Category (ytd): |
24 |
| % Rank in Category (ytd): |
2.97% |
| Beta (3y): |
0.96 |
| Morningstar Risk Rating: |
Low |
|
| The investment seeks long-term growth. The fund primarily invests in common stocks of domestic corporations with small- and medium-sized capitalizations having growth potential. It generally considers companies with market capitalizations up to $2 billion as "small," between $2 billion and $10 billion as "medium," and greater than $10 billion as "large." To a lesser extent, the fund may invest in companies with large market capitalizations. |
|
| Fund Profile |
|
Help
0.20 (1.16%) 
Summary
Add NCLEX to Portfolio 
Download Data
